228 related articles for article (PubMed ID: 28422740)
1. Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol.
Chen KE; Bustamante K; Nguyen V; Walker AM
Oncotarget; 2017 May; 8(22):36368-36382. PubMed ID: 28422740
[TBL] [Abstract][Full Text] [Related]
2. MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer.
Zheng L; Zhang Y; Liu Y; Zhou M; Lu Y; Yuan L; Zhang C; Hong M; Wang S; Li X
J Transl Med; 2015 Aug; 13():252. PubMed ID: 26238857
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells.
Savita U; Karunagaran D
Biochem Biophys Res Commun; 2013 May; 434(4):841-7. PubMed ID: 23611780
[TBL] [Abstract][Full Text] [Related]
4. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
[TBL] [Abstract][Full Text] [Related]
8. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.
Gibcus JH; Kroesen BJ; Koster R; Halsema N; de Jong D; de Jong S; Poppema S; Kluiver J; Diepstra A; van den Berg A
J Pathol; 2011 Dec; 225(4):609-17. PubMed ID: 21953646
[TBL] [Abstract][Full Text] [Related]
9. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.
Wang Z; Li TE; Chen M; Pan JJ; Shen KW
Aging (Albany NY); 2020 Jan; 12(2):1867-1887. PubMed ID: 31986487
[TBL] [Abstract][Full Text] [Related]
10. miR-19 targeting of PTEN mediates butyl benzyl phthalate-induced proliferation in both ER(+) and ER(-) breast cancer cells.
Wu J; Jiang Y; Cao W; Li X; Xie C; Geng S; Zhu M; Liang Z; Zhu J; Zhu W; Wu R; Ma X; Huang C; Yang X; Wang S; Zhong C
Toxicol Lett; 2018 Oct; 295():124-133. PubMed ID: 29864457
[TBL] [Abstract][Full Text] [Related]
11. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
12. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer.
Duan J; Zhang H; Qu Y; Deng T; Huang D; Liu R; Zhang L; Bai M; Zhou L; Ying G; Ba Y
Oncotarget; 2016 Jul; 7(28):44522-44533. PubMed ID: 27304191
[TBL] [Abstract][Full Text] [Related]
13. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Kan T; Sato F; Ito T; Matsumura N; David S; Cheng Y; Agarwal R; Paun BC; Jin Z; Olaru AV; Selaru FM; Hamilton JP; Yang J; Abraham JM; Mori Y; Meltzer SJ
Gastroenterology; 2009 May; 136(5):1689-700. PubMed ID: 19422085
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
16. Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5.
Yao YL; Wu XY; Wu JH; Gu T; Chen L; Gu JH; Liu Y; Zhang QH
Asian Pac J Cancer Prev; 2013; 14(5):2839-43. PubMed ID: 23803041
[TBL] [Abstract][Full Text] [Related]
17. miR-106b fine tunes ATG16L1 expression and autophagic activity in intestinal epithelial HCT116 cells.
Zhai Z; Wu F; Chuang AY; Kwon JH
Inflamm Bowel Dis; 2013 Oct; 19(11):2295-301. PubMed ID: 23899543
[TBL] [Abstract][Full Text] [Related]
18. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
[TBL] [Abstract][Full Text] [Related]
19. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
20. The expression and function of miRNA-106 in pediatric osteosarcoma.
Xu M; Zhang YY; Wang HF; Yang GS
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):715-722. PubMed ID: 28272712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
